Showing results (121-130 of 163) with videos related to

Sort By:
Pageof 17
Journal of the American Academy of Dermatology|July 4, 2018
Ixekizumab provides superior efficacy compared with ustekinumab over 52 weeks of treatment: Results from IXORA-S, a phase 3 studyCarle Paul, Christopher E M Griffiths, Peter C M van de Kerkhof, et al.
Dermatology and Therapy|July 23, 2025
Comparative Effectiveness and Durability of Biologics Through 24 Months for Patients with Moderate-to-Severe Psoriasis: Results from the International, Observational Psoriasis Study of Health Outcomes (PSoHO)Andreas Pinter, Alan Brnabic, Emanuele Trovato, et al.
Acta Ortopedica Mexicana|September 15, 2010
[Study of the feasibility of lateral meniscal repair including the popliteal tendon with a knee simulator]Xavier Pelfort López, Marc Tey Pons, Francisco Reina de la Torre, et al.
Transfusion|June 5, 2008
Seroprevalence of Trypanosoma cruzi infection in at-risk blood donors in Catalonia (Spain)Maria Piron, Mireia Vergés, José Muñoz, et al.
Actas Dermo-Sifiliograficas|May 19, 2009
[Reactions to infliximab infusions in dermatologic patients: consensus statement and treatment protocol. Working Group of the Grupo Español de Psoriasis de la Academia Española de Dermatología y Venereología ]Lluís Puig Sanz, E Sáez, M J Lozano, et al.
Dermatologic Therapy|September 6, 2021
Satisfactory treatment of mucocutaneous lesions in hereditary hemorrhagic telangiectasia patients with dual pulsed dye laser and neodymium: yttrium-aluminum-garnetXavier Cubiró, Cristina Garcia-Melendo, Caridad Elena Morales-Munera, et al.
Arthritis Care & Research|June 23, 2015
Maintenance of Clinical Efficacy and Radiographic Benefit Through Two Years of Ustekinumab Therapy in Patients With Active Psoriatic Arthritis: Results From a Randomized, Placebo-Controlled Phase III TrialArthur Kavanaugh, Lluís Puig, Alice B Gottlieb, et al.
Lancet (London, England)|June 18, 2013
Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trialIain B McInnes, Arthur Kavanaugh, Alice B Gottlieb, et al.
Diagnostic Microbiology and Infectious Disease|October 18, 2016
Preoperative antibiotic prophylaxis in prosthetic joint infections: not a concern for intraoperative culturesDaniel Pérez-Prieto, María E Portillo, Lluís Puig-Verdié, et al.
Antibiotics (Basel, Switzerland)|December 30, 2020
Intraoperative Bacterial Contamination and Activity of Different Antimicrobial Prophylaxis Regimens in Primary Knee and Hip ReplacementAlba Rivera, Alba Sánchez, Sonia Luque, et al.
Pageof 17